Archive for 2026

OCD Is Not What You Think It Is — The Real Meaning, Symptoms and Science Behind It

Sunday, May 17th, 2026

Obsessive-compulsive disorder is one of the most frequently misrepresented mental health conditions in everyday language. It is routinely described as a preference for tidiness, a tendency toward perfectionism, or a harmless personality quirk — none of which bear any clinical resemblance to what OCD actually is.

OCD is a serious, chronic mental health condition in which a person becomes trapped in a cycle of unwanted, distressing thoughts and repetitive behaviours they feel compelled to perform — even when those thoughts make no logical sense. The distress it causes is real, and for many people, it consumes hours of every day. Left unaddressed, it progressively affects relationships, work, and quality of life.

This article explains what OCD actually is, how it works, what drives it, and what effective treatment looks like.

What Is OCD?

OCD, in clinical terms, refers to a chronic mental health condition characterised by two defining features: obsessions and compulsions. These two components interact in a self-reinforcing cycle that, without appropriate treatment, tends to worsen over time.

Obsessions are unwanted, intrusive thoughts, images, or urges that enter the mind repeatedly and cause significant anxiety or distress. They are not chosen, not welcome, and not reflective of the person’s actual desires or values. A person with OCD does not want these thoughts — they experience them as invasive and deeply disturbing.

Compulsions are repetitive behaviours or mental acts performed in response to obsessions, with the aim of reducing the anxiety they generate or preventing a feared outcome. The relief compulsions provide is real but temporary. Within a short time, the obsession returns — and the compulsion must be repeated. This is the core of OCD.

What is OCD if not simply anxiety? It is distinguished from general anxiety by the presence of this specific obsession-compulsion cycle, by the ego-dystonic nature of the obsessions, they feel foreign and contrary to the person’s values, and by the time the cycle consumes. DSM-5 criteria require that obsessions and compulsions take up more than one hour per day and cause clinically significant distress or functional impairment.

OCD affects people across all ages, cultures, and levels of education. It commonly begins in childhood, adolescence, or early adulthood. Without treatment, it typically follows a chronic course with periods of exacerbation and partial remission.

The Obsession-Compulsion Cycle — How OCD Actually Works

Understanding the obsession-compulsion cycle is fundamental to understanding why OCD is so difficult to manage without professional support.

The cycle typically operates as follows:

  1. Trigger — an internal thought, external situation, or sensory input activates the obsession. The trigger itself may be entirely ordinary — a door handle, a sharp object, or a passing thought.
  2. Obsession — the intrusive thought, image, or urge takes hold and generates intense anxiety or discomfort.
  3. Interpretation — the person interprets the obsession as meaningful, threatening, or morally significant, amplifying the distress.
  4. Compulsion — a behaviour or mental ritual is performed to reduce anxiety, neutralise the thought, or prevent the feared outcome.
  5. Temporary relief — the anxiety decreases briefly, reinforcing the compulsion as a coping mechanism.
  6. Return of obsession — the obsession returns, often with greater intensity, and the cycle begins again.

Each compulsion prevents the brain from learning that the feared outcome would not have occurred and from experiencing the natural reduction in anxiety that comes from tolerating uncertainty. Over time, obsessions become more frequent, compulsions more elaborate, and the condition more entrenched.

OCD Symptoms — What Obsessions and Compulsions Actually Look Like

OCD symptoms are far more varied than the stereotype of handwashing or tidiness suggests. The content of obsessions reflects whatever a person holds most important or most fears — which is part of what makes them so distressing.

Common Obsession Themes

  • Contamination — fear of germs, disease, bodily fluids, or environmental contaminants, even when exposure is objectively minimal
  • Harm — intrusive thoughts about accidentally or intentionally hurting oneself or others; fear of being responsible for a catastrophic event
  • Symmetry and exactness — a need for things to be arranged or completed in a specific way until they feel “just right”; intense discomfort when they are not
  • Unwanted sexual or violent thoughts — disturbing intrusive thoughts completely contrary to the person’s values; distressing precisely because of their nature
  • Religious and moral scrupulosity — excessive concern about sin, blasphemy, or having committed a moral wrong; relentless doubt about one’s own character
  • Relationship OCD — obsessive doubt about whether one truly loves a partner or whether the relationship is right

Common Compulsion Patterns

  • Washing and cleaning — handwashing or cleaning objects and surfaces beyond what hygiene requires
  • Checking — repeatedly verifying locks, appliances, or light switches; seeking repeated reassurance that harm has not occurred
  • Arranging and ordering — placing objects in specific configurations; repeating actions until they feel symmetrically correct
  • Mental rituals — counting, praying, repeating specific words internally, or mentally reviewing events to neutralise a thought
  • Avoidance — restructuring daily life to avoid triggers; functionally a compulsion because it maintains the cycle while providing short-term anxiety relief

The Types of OCD Most People Have Never Heard Of

OCD is not a single uniform presentation. Several subtypes are clinically recognised, many of which bear no resemblance to the public image of the condition.

Pure O (Purely Obsessional OCD) A form of OCD in which compulsions are primarily mental rather than behavioural — internal reassurance-seeking, mental reviewing, or thought suppression. The absence of visible rituals leads to significant underdiagnosis.

Scrupulosity OCD Centred on religious or moral perfectionism. The person is tormented by doubt about whether they have sinned or acted immorally — regardless of reassurance or evidence to the contrary.

Relationship OCD (ROCD) Obsessive doubt focused on the validity of a romantic relationship. The person is consumed by questions about whether they truly love their partner, despite having no objective reason to doubt it.

Somatic OCD Excessive preoccupation with body sensations or automatic bodily functions such as breathing, swallowing, heartbeat — that becomes conscious and distressing through focused attention.

PANDAS/PANS-related OCD In some children, OCD symptoms develop or worsen abruptly following a streptococcal infection such as strep throat. This form — Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections — is thought to involve an autoimmune mechanism in which antibodies directed at the streptococcus bacterium cross-react with brain tissue. Assessment of this form may require collaboration between psychiatry and the department of rheumatology or immunology, given its autoimmune underpinning.

What Causes OCD — The Science Behind It

What causes OCD is not a single factor. It arises from the interaction of neurobiological, genetic, and environmental influences.

Neurological basis Neuroimaging consistently identifies abnormalities in circuits connecting the orbitofrontal cortex, anterior cingulate cortex, thalamus, and basal ganglia — a loop involved in decision-making, error detection, and behavioural inhibition. In OCD, this circuit appears hyperactive, generating persistent “error signals” that the brain interprets as requiring a corrective response — the compulsion. Serotonin and glutamate neurotransmitter systems are both implicated in this dysregulation.

Genetic factors OCD runs in families. Having a first-degree biological relative with OCD significantly increases an individual’s risk, particularly if the relative’s onset was in childhood or adolescence. Twin studies confirm a meaningful heritable component, though no single gene has been identified as the definitive cause.

Psychological and environmental factors Early life experiences, including trauma, abuse, neglect, or environments characterised by excessive responsibility or perfectionism — can shape the cognitive patterns that contribute to OCD vulnerability. Stressful life events frequently trigger or exacerbate OCD in individuals with a pre-existing neurobiological predisposition.

OCD Diagnosis — How It Is Formally Assessed

OCD diagnosis is made by a psychiatrist or clinical psychologist using criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). There is no blood test or imaging study that confirms OCD.

Diagnostic criteria require:

  • The presence of obsessions, compulsions, or both
  • Those symptoms consume more than one hour per day or cause significant distress or functional impairment
  • That symptoms are not attributable to substances, medications, or another medical condition
  • That the presentation is not better explained by another psychiatric condition

Clinical assessment typically includes a structured diagnostic interview, standardised rating scales such as the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), and evaluation of symptom severity and functional impact.

A critical clinical note: the average delay between OCD symptom onset and first clinical contact is seven to ten years. Shame, misattribution of symptoms, and a lack of awareness that what a person is experiencing is OCD, rather than personal weakness, are the primary drivers of this delay. Earlier treatment consistently produces better long-term outcomes.

OCD Treatment — What Actually Works

OCD treatment has a well-established evidence base. While OCD is a chronic condition in most cases, meaningful symptom reduction and functional recovery are achievable for the majority of patients.

Exposure and Response Prevention (ERP) ERP is the gold standard psychological treatment for OCD. It is a structured form of cognitive behavioural therapy in which the patient is progressively exposed to anxiety-provoking stimuli related to their obsessions, while being supported in refraining from the compulsive response. Over repeated exposures, the anxiety generated by the obsession naturally decreases without the compulsion — breaking the reinforcement cycle and restoring the brain’s ability to tolerate uncertainty.

Pharmacotherapy Selective serotonin reuptake inhibitors (SSRIs) — including fluoxetine, sertraline, fluvoxamine, and paroxetine — are the first-line pharmacological agents for OCD. They reduce the intensity and frequency of obsessions and compulsions in a significant proportion of patients. OCD typically requires higher doses than those used for depression, and response develops over a longer timeframe. Clomipramine, a tricyclic antidepressant with strong serotonergic activity, is used when SSRIs are insufficient.

Combined treatment The combination of ERP and pharmacotherapy produces better outcomes than either approach alone for most patients with moderate to severe OCD.

Advanced interventions for treatment-resistant OCD For patients who do not respond adequately to multiple treatment trials, augmentation strategies including antipsychotic addition, intensive ERP programs, transcranial magnetic stimulation (TMS), and, in carefully selected cases, deep brain stimulation are considered. The best neuro rehabilitation centre in India, with expertise in treatment-resistant psychiatric conditions and neurostimulation, provides the most structured pathway for patients whose OCD has not responded to standard treatment.

For initial assessment, accurate diagnosis, and development of a comprehensive OCD treatment plan, consultation with the best psychiatrist in India with specialist expertise in OCD and anxiety disorders is the most important first step.

Common OCD Myths — Formally Debunked

Myth: OCD is about being clean or organised OCD can involve contamination themes, but the majority of OCD presentations have nothing to do with cleanliness. Harm, religion, relationships, intrusive thoughts, and somatic preoccupations are equally common — and far less visible.

Myth: People with OCD can just stop if they try hard enough Compulsions are not choices. They are driven by intense anxiety and reinforced by temporary relief. Willpower alone does not break the obsession-compulsion cycle — structured treatment does.

Myth: OCD is caused by poor parenting or weak character OCD is a neurobiological condition with identifiable brain circuit abnormalities and a genetic component. It is not a reflection of character, willpower, or upbringing.

Myth: OCD always involves visible rituals Many people with OCD perform purely mental compulsions — internal reviewing, reassurance-seeking, thought suppression — with no visible behavioural signs. These presentations are frequently missed or misdiagnosed.

Myth: OCD is rare OCD affects approximately one to two percent of the global population, making it one of the more prevalent mental health conditions worldwide. It is underdiagnosed, but not uncommon.

Conclusion

OCD is not a personality trait. It is not a preference for tidiness, a tendency toward perfectionism, or a sign of being detail-oriented. It is a clinically significant, neurologically grounded condition that traps individuals in a cycle of distressing intrusive thoughts and time-consuming compulsive behaviours — a cycle that, without appropriate treatment typically intensifies over time.

The most important clinical message is this: OCD is treatable. Exposure and Response Prevention therapy, pharmacological intervention, and where needed, advanced neurostimulation approaches produce meaningful recovery for the majority of patients. The barrier is rarely the availability of treatment — it is the delay in reaching it.

If you or a family member is experiencing intrusive thoughts, repetitive behaviours, or a pattern of anxiety-driven rituals that is consuming time and interfering with daily life, a clinical evaluation is the right next step. At Kokilaben Dhirubhai Ambani Hospital, our psychiatry team provides specialist assessment and evidence-based management for OCD across all age groups and presentations. Book a consultation today.

Frequently Asked Questions

Q1. Can OCD develop suddenly in adulthood with no prior history — and what usually triggers it? 

Yes. While OCD most commonly begins in childhood or early adulthood, new onset in later adulthood does occur. Common triggers include significant life stressors, bereavement, childbirth (postpartum OCD), major health events, and in some cases, neurological illness or infection.

Q2. Is OCD more common in men or women — and does it present differently across genders? 

OCD affects men and women at roughly equal rates overall. Men tend to develop it earlier — in childhood or adolescence — while women more commonly develop it in early adulthood. Contamination and checking themes are somewhat more prevalent in women; symmetry and forbidden thought themes are somewhat more common in men.

Q3. Can OCD go into remission on its own — and what causes it to flare up? 

Partial remission can occur, particularly in adolescence, but full spontaneous resolution without treatment is uncommon. Flare-ups are typically associated with stress, major life transitions, sleep disruption, illness, or hormonal changes.

Q4. How does OCD affect children — and how do parents recognise it versus normal childhood anxiety? 

OCD in children often presents as avoidance of specific situations, elaborate bedtime rituals, repeated reassurance-seeking, or sudden deterioration in school performance. Normal childhood anxiety is typically transient and proportionate. OCD is persistent, time-consuming, and significantly distressing, and the child is usually aware that their thoughts or behaviours are not quite right.

Q5. Is there a connection between OCD and gut health — and does nutrition affect OCD severity? 

Emerging research suggests a gut-brain axis connection, with gut microbiome composition potentially influencing serotonin production and neuroinflammatory pathways relevant to OCD. While nutrition is not a treatment for OCD, diets that support gut health and reduce systemic inflammation may complement clinical management. This remains an active area of research rather than established clinical guidance.

How Menopause Affects Your Bone, Heart and Brain Health

Sunday, May 17th, 2026

Menopause is a natural biological transition, but the way it is discussed, often reduced to hot flushes and mood changes, significantly understates its clinical significance. The decline in oestrogen that defines menopause does not affect one system in isolation. It has measurable, well-documented consequences for bone density, cardiovascular function, and cognitive health that begin during perimenopause and compound over the following years.

For many women, the most serious health risks associated with menopause are not the visible or uncomfortable symptoms. They are the ones that develop silently, without obvious signals, over years. Understanding these risks and acting on them before they become established conditions is not a matter of choice; it is a medical priority.

What Is Menopause?

Menopause is defined as the point at which a woman has not had a menstrual period for twelve consecutive months, marking the permanent end of ovarian reproductive function. It is a physiological process driven by the progressive depletion of ovarian follicles and the corresponding decline in the production of oestrogen and progesterone, the two primary female reproductive hormones.

Menopause occurs in three clinical phases:

Perimenopause is the transitional phase preceding menopause, often beginning in the mid to late 40s. Ovarian hormone production becomes irregular and gradually declines. Most of the symptomatic experience of menopause, including hot flushes, sleep disruption, and mood changes, begins during perimenopause, which can last between two and eight years.

Menopause itself is the single point in time, confirmed retrospectively after twelve months without menstruation, at which ovarian function has effectively ceased. The average age of natural menopause in India is between 46 and 48 years, somewhat earlier than the global average.

Postmenopause refers to all years following that point. Oestrogen levels remain low and stable. It is in the postmenopausal period that the cumulative effects of oestrogen deficiency on bone, heart, and brain become most clinically significant.

Premature and early menopause  occurring before age 40 or between 40 and 45 respectively, carries amplified long-term health risks because of the extended duration of low oestrogen. It may result from surgical removal of the ovaries, chemotherapy, radiation, or autoimmune conditions.

Common Signs and Symptoms of Menopause

Menopause symptoms vary considerably in type, severity, and duration. They arise from the hormonal fluctuations of perimenopause and the sustained oestrogen deficiency of the postmenopausal state. Recognising the signs of menopause early allows for timely medical evaluation and intervention.

Vasomotor symptoms

  • Hot flushes — sudden episodes of intense warmth affecting the face, neck, and chest, often with visible flushing and perspiration
  • Night sweats — hot flushes during sleep, frequently disrupting sleep quality and duration

Genitourinary symptoms

  • Vaginal dryness, thinning of vaginal tissue, and discomfort during intercourse
  • Increased frequency of urinary tract infections and urinary urgency which is a condition termed Genitourinary Syndrome of Menopause (GSM)

Menstrual changes

  • Irregular, heavier, lighter, or less frequent periods during perimenopause before cessation

Mood and psychological symptoms

  • Irritability, low mood, and increased anxiety, particularly during perimenopause when hormonal fluctuations are most pronounced
  • Reduced sense of well-being and motivation

Sleep disturbance

  • Difficulty falling or staying asleep, compounded by night sweats and heightened anxiety

Physical changes

  • Reduced skin collagen and elasticity
  • Changes in hair texture and density
  • Redistribution of body fat toward the abdomen

Cognitive symptoms

  • Memory lapses, poor concentration, and word-finding difficulties, commonly referred to as menopause-related brain fog

Understanding what menopause and its wide-ranging effects are is the foundation for managing it well. The side effects of menopause extend far beyond the familiar vasomotor symptoms, and many of its most consequential effects receive far less attention than they deserve.

How Menopause Affects Bone Health

Oestrogen plays a central role in maintaining bone density. It regulates the balance between osteoblasts, cells responsible for building new bone, and osteoclasts, cells that break down old bone. As long as oestrogen is adequate, this process remains in balance and bone density is preserved.

With the oestrogen decline of menopause, this balance is disrupted. Osteoclast activity accelerates while osteoblast activity does not proportionally increase, resulting in a net loss of bone density. Bone loss is most rapid in the first three to five years following menopause, though it continues at a slower rate throughout the postmenopausal years.

The clinical outcome of sustained bone loss is osteoporosis, a condition in which bone density falls to a level where fracture risk increases significantly. Osteoporotic fractures most commonly affect the hip, spine, and wrist. Hip fractures carry particularly serious consequences for older women, including prolonged immobility, loss of independence, and increased mortality risk.

Risk Factors That Compound Menopause-Related Bone Loss

  • Low body weight — lean women have lower baseline bone density and less mechanical loading
  • Smoking — directly impairs osteoblast activity and accelerates oestrogen clearance
  • Low dietary calcium and vitamin D intake — both are essential for bone mineralisation
  • Physical inactivity — weight-bearing exercise is a primary stimulus for bone formation
  • Family history of osteoporosis or hip fracture
  • Prolonged corticosteroid use
  • Early or premature menopause — a longer duration of oestrogen deficiency means greater cumulative loss

A bone mineral density assessment via DEXA scan is the standard investigation for evaluating bone health in postmenopausal women, particularly those with risk factors. This should be discussed with a doctor within the first few years following menopause.

For women already diagnosed with significant bone loss, structured osteoporosis treatment, combining lifestyle modification, calcium and vitamin D supplementation, and, where indicated, pharmacological agents such as bisphosphonates, substantially reduces fracture risk and slows further bone loss.

How Menopause Affects Heart Health

Before menopause, oestrogen provides a meaningful protective effect on the cardiovascular system. It supports the elasticity of blood vessel walls, maintains favourable cholesterol ratios, reduces arterial inflammation, and promotes healthy endothelial function. As oestrogen levels fall during and after menopause, these protective mechanisms diminish progressively.

The cardiovascular consequences of menopause include:

Worsening lipid profile After menopause, LDL cholesterol tends to rise and HDL cholesterol tends to fall, creating a lipid environment that accelerates plaque formation in arterial walls. Triglyceride levels also increase, further elevating cardiovascular risk.

Rising blood pressure Oestrogen contributes to the regulation of vascular tone. Its decline is associated with a progressive rise in systolic and diastolic blood pressure. Many women who maintained normal blood pressure throughout their reproductive years develop hypertension in the postmenopausal period.

Increased arterial stiffness Loss of oestrogen’s vasodilatory effect accelerates the stiffening of arterial walls, increasing cardiac workload and raising the risk of heart attack and stroke.

Central adiposity The hormonal shift of menopause promotes abdominal fat accumulation, the form of adiposity most strongly associated with insulin resistance, metabolic syndrome, and cardiovascular disease.

Elevated inflammatory markers Postmenopausal women frequently show elevated levels of inflammatory markers such as C-reactive protein, which are independently associated with increased cardiovascular risk.

It is a persistent clinical misconception that heart disease is primarily a male condition. In the decades following menopause, women’s cardiovascular risk increases substantially. The absence of classic chest pain as a presenting symptom — women more frequently present with atypical features such as fatigue, breathlessness, and jaw or back discomfort — contributes to delayed diagnosis.

Regular cardiovascular assessment — blood pressure monitoring, lipid profiling, fasting blood glucose, and cardiac evaluation where indicated — should be a structured component of postmenopausal healthcare. Women with established cardiovascular risk factors or symptoms should seek evaluation at the best cardiac hospital with experience in women’s heart health.

How Menopause Affects Brain Health

The brain is a significant target organ for oestrogen. Oestrogen receptors are distributed throughout the brain, particularly in regions governing memory, mood, executive function, and neurological repair. Oestrogen supports cerebral blood flow, the synthesis of neurotransmitters including serotonin and acetylcholine, and neuroprotective processes that limit amyloid accumulation — the protein implicated in Alzheimer’s disease.

When oestrogen declines during menopause, the brain undergoes a period of neurological adaptation that many women experience as subjective cognitive change. This is one of the most frequently reported yet least clinically addressed side effects of menopause.

Cognitive Symptoms During Menopause

  • Memory lapses — difficulty retaining recently acquired information or recalling familiar names and details
  • Concentration difficulties — reduced ability to sustain focus, particularly in cognitively demanding settings
  • Mental fatigue — a sense of cognitive effort disproportionate to the task at hand
  • Word-finding difficulties — losing words mid-sentence or substituting incorrect ones

These menopause symptoms are real, measurable neurological phenomena — not purely psychological responses to the stress of the transition. Research increasingly supports the view that the brain adapts to its new hormonal environment over time, and that for most women, these symptoms improve in the years following menopause.

Menopause, Depression, and Anxiety

The hormonal fluctuations of perimenopause significantly affect mood regulation. As oestrogen levels fluctuate and decline, many women experience:

  • Onset or worsening of depression, even without a prior psychiatric history
  • Increased anxiety and generalised worry
  • Emotional volatility and reduced stress tolerance
  • Sleep disruption that compounds mood and cognitive symptoms

Women with a history of premenstrual syndrome, postpartum depression, or clinical depression are at higher risk of significant mood disturbance during the menopausal transition. These presentations require clinical evaluation and management, not normalisation.

Long-Term Neurological Risk

The relationship between menopause and dementia is an active and evolving area of research. Evidence increasingly suggests that an extended period of oestrogen deficiency, particularly in women with early or premature menopause, is associated with a higher lifetime risk of Alzheimer’s disease. The mechanisms likely involve reduced neuroprotection, accelerated amyloid deposition, and decreased cerebral blood flow in the postmenopausal brain.

Women experiencing persistent or distressing mood and cognitive changes during or after menopause should seek clinical assessment. Structured support, whether through pharmacological management, psychological therapy, or both, can meaningfully improve quality of life and reduce the risk of longer-term psychological and neurological consequences.

When Should You See a Doctor?

Menopause is a normal life transition, but its effects on bone, heart, and brain are clinical concerns that benefit from proactive medical management. Consult a gynaecologist or menopause specialist when:

  • Menopause symptoms — hot flushes, sleep disruption, mood disturbances, or cognitive changes, are significantly affecting daily functioning
  • Periods become highly irregular, very heavy, or associated with intermenstrual bleeding that warrants investigation
  • You experience any signs of menopause before the age of 45
  • You have risk factors for osteoporosis and have not had a bone density assessment
  • Cardiovascular risk factors — elevated blood pressure, abnormal cholesterol, or weight gain — have developed or worsened in the postmenopausal period
  • Mood disturbances are persistent and do not resolve with time

Proactive consultation allows treatment decisions to be made when options are broadest, particularly regarding hormone replacement therapy (HRT), bone protection, and cardiovascular risk reduction. The timing and duration of HRT, its suitability for an individual woman, and its risk-benefit profile are decisions best made in consultation with a specialist who can assess the complete clinical picture.

Conclusion

Menopause is a biological transition with consequences that extend well beyond the symptomatic discomforts most commonly associated with it. Its effects on bone density, cardiovascular health, and brain function are clinically significant, progressive, and in many cases preventable or modifiable — but only when identified and managed proactively.

The signs of menopause that deserve the most attention are often the least visible. Bone loss, rising blood pressure, worsening lipid profiles, and cognitive change do not occur in the early stages. By the time they do, intervention is more complex, and outcomes are less favourable.

At Kokilaben Dhirubhai Ambani Hospital, our obstetrics, gynaecology, and menopause care teams provide comprehensive evaluations for women at every stage of the menopausal transition, from symptom management and hormonal assessment to bone health screening, cardiovascular risk profiling, and psychological support. If you are approaching or have reached menopause, a structured consultation is the most productive step you can take for your long-term health. Book an appointment with our specialists today.

Frequently Asked Questions

At what age does menopause typically start in Indian women? 

The average age of natural menopause in Indian women is between 46 and 48 years, earlier than the global average of approximately 51 years. Perimenopause, the transitional phase with irregular cycles and symptoms, may begin several years before this.

Is weight gain during menopause inevitable? 

Not entirely, but hormonal changes do promote abdominal fat redistribution. Consistent physical activity, dietary discipline, and, where appropriate, medical management can limit the extent of weight gain and reduce its associated health risks.

Can menopause increase the risk of Alzheimer’s disease? 

Evidence suggests that prolonged oestrogen deficiency, particularly from early or premature menopause, is associated with a higher risk of Alzheimer’s disease. The relationship is still under investigation, but it underscores the importance of monitoring brain health after menopause.

Is hormone replacement therapy (HRT) safe? 

For most healthy women under 60 or within ten years of menopause onset, the benefits of HRT outweigh the risks for managing menopause symptoms and protecting bone health. Suitability is individual and must be assessed by a specialist, taking into account personal medical history.

How long do menopause symptoms last? 

Menopause symptoms vary considerably in duration. Hot flushes and night sweats typically last four to eight years, though some women experience them for longer. Genitourinary and cognitive symptoms may persist indefinitely without treatment.

What Is Targeted Therapy for Cancer? A Complete Guide

Tuesday, May 12th, 2026

Cancer treatment has changed considerably over the past two decades. Where chemotherapy and radiation were once the primary tools available, oncology now has access to a growing class of treatments designed with far greater precision. Targeted therapy for cancer is among the most significant of these advances, not because it replaces other treatments, but because it approaches cancer in a fundamentally different way.

Unlike chemotherapy, which acts broadly on all rapidly dividing cells, targeted therapy identifies and acts on specific molecular structures that drive cancer growth. The result is a treatment approach that is, in many cases, more precise, better tolerated, and capable of producing meaningful outcomes even in cancers that have not responded to conventional treatment. Understanding what targeted therapy is, how it works, and who it is appropriate for is increasingly important for patients and families navigating a cancer diagnosis.

What Is Targeted Therapy in Cancer?

Targeted therapy is a form of cancer treatment that acts on specific proteins, genes, or cellular pathways that cancer cells depend on to grow, divide, and survive. These molecular targets are identified through testing of the tumour’s genetic and molecular profile, a process called biomarker testing or molecular profiling.

Cancer cells develop because of changes, mutations, in the DNA of normal cells. These mutations produce abnormal proteins that drive uncontrolled cell growth. Targeted therapy for cancer is designed to interfere with these specific abnormal proteins, blocking the signals that allow the tumour to grow and spread.

This is what distinguishes targeted therapy from conventional chemotherapy. Chemotherapy is broadly cytotoxic, it disrupts cell division across the board, affecting both cancerous and healthy cells. Targeted therapy acts selectively on the molecular mechanisms that are specifically active in cancer cells, which is why it is often described as a component of precision medicine or personalised cancer treatment.

Not every patient with a given cancer type will be a candidate for the same targeted agent. Eligibility depends on whether the individual tumour carries the molecular target that the drug is designed to act on. Two patients with the same cancer diagnosis may receive entirely different targeted therapies, or one may receive targeted therapy while the other does not, based on what the molecular testing reveals.

How Does Targeted Therapy Work?

At its core, targeted therapy for cancer works by disrupting the specific biological processes that cancer cells rely on. The mechanisms through which this occurs include:

Blocking growth signals Normal cells divide only when they receive signals instructing them to do so. These signals bind to proteins on the cell surface called receptors. In many cancers, the receptors or the signalling pathways they activate are abnormally overactive, causing cells to divide continuously without proper regulation. Targeted drugs can block these receptors or interfere with the downstream signalling proteins, interrupting the growth signal.

Inhibiting blood vessel formation (angiogenesis) Tumours require a blood supply to grow beyond a certain size. They achieve this by releasing signals that stimulate the formation of new blood vessels — a process called angiogenesis. A class of targeted agents known as angiogenesis inhibitors block these signals, depriving the tumour of the vascular supply it needs to grow and sustain itself.

Triggering cancer cell death (apoptosis) In healthy cells, a built-in process of programmed cell death removes damaged or abnormal cells before they can proliferate. Many cancer cells evade this process. Some targeted therapies restore or directly activate the apoptotic pathway, causing cancer cells to self-destruct.

Delivering cytotoxic agents directly to cancer cells A subset of targeted treatments, called antibody-drug conjugates (ADCs), combine a monoclonal antibody with a chemotherapy or toxin payload. The antibody homes in on the target protein on the cancer cell’s surface and delivers the cytotoxic agent directly to the cell, minimising exposure to surrounding healthy tissue.

Supporting immune recognition Certain targeted therapies mark cancer cells with molecules that make them more visible to the immune system, facilitating their destruction by the body’s own immune response. This is distinct from immunotherapy, though the two share some overlapping mechanisms.

Types of Targeted Therapy

Targeted therapy for cancer encompasses several categories of drugs, each with a distinct mechanism and application.

Small-Molecule Inhibitors

These are drugs small enough to enter cells directly and interfere with proteins that function inside the cell. They are commonly used when the molecular target is located within the cell rather than on its surface. Examples include tyrosine kinase inhibitors (TKIs) such as imatinib (used in chronic myelogenous leukaemia), erlotinib and gefitinib (used in certain lung cancers), and lapatinib (used in HER2-positive breast cancer). PARP inhibitors, used in BRCA-mutated breast and ovarian cancers, also fall within this category.

Monoclonal Antibodies

These are laboratory-produced proteins designed to attach to specific targets on the surface of cancer cells. Once attached, they can:

  • Block growth factor receptors from receiving signals
  • Flag the cancer cell for destruction by the immune system
  • Deliver a toxic payload directly to the target cell

Well-known examples include trastuzumab (Herceptin), used in HER2-positive breast and gastric cancer; rituximab, used in B-cell lymphomas; bevacizumab, an angiogenesis inhibitor used in colorectal, lung, and other cancers; and cetuximab, used in certain colorectal and head and neck cancers.

Antibody-Drug Conjugates (ADCs)

ADCs are an advancing category that links a monoclonal antibody to a chemotherapy agent. The antibody delivers the chemotherapy directly to cells carrying the specific target protein. This approach improves the precision of chemotherapy delivery and is an active area of drug development in breast, bladder, and gastric cancer.

Proteasome Inhibitors

These drugs block the proteasome, a cellular structure responsible for breaking down damaged or abnormal proteins. When the proteasome is inhibited, these proteins accumulate and disrupt the cancer cell’s normal function, ultimately causing cell death. Bortezomib and carfilzomib are examples used in multiple myeloma.

mTOR Inhibitors and CDK Inhibitors

mTOR inhibitors target a protein that regulates cell growth and metabolism, used in hormone receptor-positive breast cancer and certain kidney cancers. CDK 4/6 inhibitors, such as palbociclib and ribociclib, block proteins that drive cell cycle progression and are a standard of care in advanced hormone receptor-positive breast cancer.

Which Cancers Can Be Treated with Targeted Therapy?

Targeted therapy for cancer is now approved and used across a wide range of cancer types. The applicability depends on whether the tumour carries the relevant molecular target.

Breast cancer HER2-positive breast cancer is treated with trastuzumab, pertuzumab, and newer ADCs such as trastuzumab deruxtecan. Hormone receptor-positive advanced breast cancer is treated with CDK 4/6 inhibitors and mTOR inhibitors. BRCA-mutated breast cancer is treated with PARP inhibitors.

Lung cancer Non-small cell lung cancer (NSCLC) with EGFR mutations, ALK rearrangements, ROS1 rearrangements, and other driver mutations is treated with targeted tyrosine kinase inhibitors. Molecular testing is now standard before first-line treatment decisions in NSCLC.

Leukaemia and lymphoma Chronic myelogenous leukaemia (CML) with the BCR-ABL fusion gene was one of the first cancers successfully treated with targeted therapy — imatinib transformed outcomes in this disease. Rituximab is a standard component of treatment in B-cell non-Hodgkin lymphoma.

Colorectal cancer Anti-VEGF agents (bevacizumab) and anti-EGFR agents (cetuximab, panitumumab) are used in RAS wild-type metastatic colorectal cancer.

Melanoma BRAF-mutated melanoma is treated with BRAF and MEK inhibitors, which have produced significant improvements in outcomes for advanced disease.

Gastrointestinal stromal tumours (GIST) KIT and PDGFRA mutations in GIST are directly targeted by imatinib and related agents.

Other cancers Targeted agents are also approved or under evaluation in thyroid cancer, kidney cancer, ovarian cancer, bladder cancer, gastric and gastroesophageal junction cancer, and multiple myeloma, among others.

How Is Targeted Therapy Administered?

The mode of administration varies depending on the specific drug and the cancer being treated.

Oral tablets or capsules Many small-molecule targeted agents are taken as daily oral medications. This allows outpatient treatment without the need for infusion visits, though adherence and monitoring of side effects remain important.

Intravenous infusion Monoclonal antibodies are typically administered as intravenous infusions in a clinical setting. Infusion frequency varies by drug — some are given weekly, others every three weeks or monthly — and infusion sessions may take between 30 minutes and several hours.

Subcutaneous injection Some monoclonal antibodies, such as certain formulations of trastuzumab, are available as subcutaneous injections, which are faster to administer and do not require intravenous access.

Targeted therapy may be used as the primary treatment, in combination with chemotherapy or hormonal therapy, before surgery (neoadjuvant), after surgery (adjuvant) to reduce recurrence risk, or in the metastatic setting to control disease spread.

What Are the Side Effects of Targeted Therapy?

Targeted therapy side effects are generally distinct from those of chemotherapy, though they are not absent. Because targeted drugs act on specific molecular pathways, the side effect profile reflects the tissues and systems in which those pathways are also active in normal biology.

Common targeted therapy side effects include:

  • Skin and nail changes — rash, dry skin, hand-foot syndrome (redness, peeling, and tenderness of the palms and soles), and nail changes are among the most frequently reported side effects, particularly with EGFR inhibitors
  • Hypertension — elevated blood pressure is a well-recognised side effect of angiogenesis inhibitors such as bevacizumab, requiring active monitoring and management
  • Fatigue — common across most targeted agents, though generally less severe than chemotherapy-related fatigue in many patients
  • Gastrointestinal effects — diarrhoea, nausea, and mouth sores occur with several classes of targeted agents, including CDK inhibitors and some TKIs
  • Liver toxicity — elevated liver enzymes are monitored through regular blood tests during targeted therapy; significant hepatotoxicity requires dose adjustment or cessation
  • Wound healing impairment — angiogenesis inhibitors can impair surgical wound healing and typically require a washout period before and after surgical procedures
  • Cardiac effects — certain agents, particularly trastuzumab and some TKIs, require baseline and periodic cardiac monitoring due to their potential effect on heart function
  • Haematological changes — reduced white blood cell or platelet counts occur with some targeted agents, particularly CDK 4/6 inhibitors, requiring dose modifications in some patients
  • Infusion reactions — for intravenously administered monoclonal antibodies, infusion-related reactions including fever, chills, and flushing can occur, particularly with the first administration

Managing targeted therapy side effects requires active collaboration between the patient and the oncology team. Many side effects are manageable with appropriate supportive care, dose adjustments, or temporary treatment interruptions. Patients should report new or worsening symptoms promptly rather than tolerating them in silence.

What to Expect During Treatment at Kokilaben Dhirubhai Ambani Hospital

At Kokilaben Dhirubhai Ambani Hospital, the approach to targeted therapy for cancer begins before treatment — with a thorough molecular and pathological evaluation of the tumour to establish eligibility for specific agents and to guide the most appropriate treatment strategy.

Diagnosis and molecular profiling All patients being considered for targeted therapy undergo comprehensive biomarker testing. This includes immunohistochemistry (IHC), fluorescence in situ hybridisation (FISH), and next-generation sequencing (NGS) where indicated, to identify the specific molecular targets present in the tumour. The results of this profiling directly inform the treatment plan.

Multidisciplinary tumour board review Each case is reviewed by a multidisciplinary oncology team comprising medical oncologists, surgical oncologists, radiation oncologists, pathologists, and radiologists. This collaborative review ensures that the decision to use targeted therapy is made in the context of the complete clinical picture.

Treatment planning and administration Oral targeted agents are initiated with a structured patient education session covering dosing, administration, potential side effects, and when to seek urgent review. Intravenous targeted therapies are administered in KDAH’s dedicated oncology day care unit under nursing supervision.

Monitoring and response assessment Regular blood tests, imaging, and clinical assessments track treatment response and detect toxicities early. Treatment adjustments are made based on objective response criteria and tolerability.

For families seeking a comprehensive cancer care pathway — from diagnosis through molecular testing, treatment, and supportive care — the best cancer hospital in India combines the full spectrum of oncological expertise under one roof. Our medical oncology department is equipped with the latest targeted agents and the diagnostic infrastructure required to deploy them precisely. For individuals seeking an initial consultation or a second opinion on a cancer diagnosis, a cancer specialist doctor at Kokilaben Dhirubhai Ambani Hospital can provide a thorough evaluation and a clearly structured management plan.

Conclusion

Targeted therapy for cancer represents a clinically meaningful advance in the treatment of many cancer types. By acting on the specific molecular drivers of individual tumours rather than broadly suppressing cell division, it has improved outcomes, expanded treatment options for cancers previously resistant to chemotherapy, and in many cases reduced the severity of treatment-related side effects.

It is not a universal solution. Eligibility depends on the molecular characteristics of the tumour, and resistance remains a clinical challenge. But for patients whose cancers carry the relevant targets, it has fundamentally changed what is possible in terms of disease control, quality of life during treatment, and long-term outcomes.

At Kokilaben Dhirubhai Ambani Hospital, our oncology programme integrates molecular diagnostics, multidisciplinary expertise, and access to current targeted agents to ensure that every patient receives a treatment plan that reflects the specific biology of their disease. If you or a family member has received a cancer diagnosis and would like to understand whether targeted therapy is an appropriate option, we encourage you to book a consultation with our oncology team today.

Frequently Asked Questions

Is targeted therapy the same as immunotherapy? 

No. Targeted therapy acts on specific proteins that drive cancer cell growth. Immunotherapy works by activating or modifying the immune system to recognise and destroy cancer cells. Some drugs have overlapping mechanisms, but they are distinct treatment categories.

Can targeted therapy cure cancer? 

In a small number of cases, such as certain leukaemias and GIST, targeted therapy can produce deep, sustained remissions equivalent to a functional cure. In most solid tumours, particularly in advanced stages, it controls disease and extends survival rather than curing it outright.

How long does targeted therapy treatment last? 

Duration varies by cancer type, treatment intent, and response. Some patients take oral targeted agents for years. Others receive treatment for a defined number of cycles. Treatment continues as long as the cancer is responding and side effects are tolerable.

What happens if targeted therapy stops working? 

Cancer cells can develop resistance mechanisms over time. When this occurs, oncologists may switch to an alternative targeted agent, a different drug class, or a combination strategy. Repeat molecular testing of the tumour is often performed to identify the resistance mechanism and guide the next treatment decision.

Is targeted therapy available in India? 

Yes. A growing number of targeted agents are now approved by the Central Drugs Standard Control Organisation (CDSCO) and available in India. Leading cancer centres including KDAH have access to molecular testing infrastructure and a range of targeted therapies across breast, lung, colorectal, haematological, and other cancers.

Alzheimer’s Disease Is Not Just Old Age — And That Confusion Is Dangerous

Sunday, May 3rd, 2026

When a parent starts forgetting names, asking the same question twice in the span of minutes, or losing their train of thought mid-sentence, most families chalk it up to old age. It feels like a reasonable explanation. So they adjust, accommodate, and wait, sometimes for years, before anyone seeks a medical opinion.

Dr. Annu Aggarwal

● Author

Dr. Annu Aggarwal

Neurology  ·  Cognitive & Behavioural Neurology

Consultant, Neurology  ·  Memory, Wilson Disease & Movement Disorders

MBBS, MD (Medicine), DNB (Neurology), MRCP (UK)  ·  KDAH Mumbai  ·  English, Marathi, Hindi


25+
Years Exp.
54+
Publications
MRCP
UK
AAN
Member

That delay has consequences. In Alzheimer’s disease, the earlier it is identified, the more that can be done to slow its progression and preserve quality of life. Mistaking the early signs of Alzheimer’s for normal ageing is not just a common misunderstanding; it is one that directly affects how well the condition can be managed.

What Is Alzheimer’s Disease And What It Isn’t

Alzheimer’s disease is a progressive, neurodegenerative condition that causes the gradual destruction of brain cells. It is the most common cause of dementia, accounting for the majority of dementia diagnoses globally. The disease damages the regions of the brain responsible for memory, reasoning, language, and behaviour, and it does so irreversibly and incrementally over time.

What Alzheimer’s disease is not is a normal or inevitable consequence of growing older. While age is the single greatest risk factor, ageing itself does not cause Alzheimer’s. Millions of people live into their 80s and 90s with their mental abilities fully intact.

The distinction matters because dismissing early symptoms as “just getting older” delays evaluation, diagnosis, and access to treatment that can meaningfully slow the disease’s progression.

India’s Alzheimer’s Crisis — Numbers Most Families Don’t Know

India is home to one of the world’s fastest-ageing populations, and Alzheimer’s disease is increasingly being recognised as a significant public health concern. Dementia, of which Alzheimer’s is the predominant form, affects millions of elderly Indians, yet awareness remains critically low.

Several factors compound the problem in the Indian context:

  • Social normalisation of cognitive decline – forgetfulness in older adults is widely accepted as expected, reducing the likelihood that families seek medical evaluation
  • Stigma around neurological and psychiatric diagnoses – many families delay or avoid a formal diagnosis to protect the patient and themselves from social judgement
  • Limited access to specialist neurological care – outside major cities, access to neurologists with expertise in dementia evaluation remains inadequate
  • Caregiver burden falling on families – unlike in many Western countries, institutional care for dementia patients is rare in India; the weight of day-to-day caregiving falls almost entirely on family members, often without clinical guidance or support

Understanding that Alzheimer’s is a medical condition, not a social embarrassment or an unavoidable part of ageing, is the first and most important shift Indian families need to make. 

How Does Alzheimer’s Disease Cause?

At its biological core, Alzheimer’s disease is caused by an abnormal accumulation of two proteins in the brain: amyloid and tau.

Amyloid plaques form when fragments of amyloid protein clump together between nerve cells, disrupting communication between neurons.

Tau tangles develop when tau proteins, which normally help maintain the internal structure of nerve cells, twist into abnormal fibres that interfere with the transport of essential nutrients within neurons.

Together, these plaques and tangles progressively damage and destroy brain cells. The destruction typically begins in the hippocampus, the brain region most involved in forming new memories, and then spreads to other regions over time. By the time symptoms become noticeable, significant neurological damage has often already occurred. Research suggests that these protein changes may begin accumulating in the brain a decade or more before any symptoms appear. 

 Risk Factors for Alzheimer’s Disease

While the exact causes of Alzheimer’s disease are still being studied, several risk factors are well established:

  • Age — the risk increases significantly after the age of 65
  • Family history and genetics — having a first-degree biological relative with Alzheimer’s raises the risk meaningfully; certain gene variants, particularly APOE ε4, are associated with higher susceptibility
  • Cardiovascular risk factors — high blood pressure, diabetes, high cholesterol, and obesity are all associated with increased Alzheimer’s risk, likely through their effects on cerebral blood flow
  • Traumatic brain injury — a history of significant head injury raises long-term risk
  • Low cognitive and social engagement — limited mental stimulation and social isolation over a lifetime may reduce cognitive reserve
  • Smoking — associated with accelerated brain ageing and vascular damage
  • Sleep disruption — emerging research points to poor sleep as a factor in amyloid accumulation in the brain

What Are Alzheimer’s Disease Symptoms?

Alzheimer’s disease symptoms do not present all at once. They accumulate gradually, often beginning with subtle changes that are easy to rationalise or overlook.

Memory Memory loss is the hallmark early symptom, particularly difficulty retaining recently acquired information. Forgetting a conversation from an hour ago, asking the same question multiple times in a short span, or failing to recall a recent event are characteristic of Alzheimer’s memory impairment. This is qualitatively different from occasionally misplacing keys or momentarily forgetting a name.

Reasoning and Planning Difficulty following a sequence of steps, whether managing finances, following a recipe, or organising a plan, is a common early sign. The person may take an unusually long time to reach simple decisions or may become unable to complete tasks that were once routine.

Language Struggling to find words, stopping mid-sentence, substituting incorrect words, or becoming noticeably less communicative than before are all Alzheimer’s-related language changes.

Behaviour and Personality Changes in mood, personality, and social behaviour are frequently observed. A person may become more suspicious, anxious, withdrawn, or uncharacteristically irritable. Paranoia, agitation, and, in later stages, hallucinations may occur.

Spatial Awareness Difficulty judging distances, navigating familiar environments, or performing actions that require fine motor coordination may also appear as the disease progresses.

Stages of Alzheimer’s — What Each One Actually Looks Like

Alzheimer’s disease is typically described across three broad stages, each with distinct functional and behavioural characteristics.

Early Stage (Mild)

The person remains largely independent. Symptoms are subtle: occasional memory gaps, mild word-finding difficulties, slight difficulty with complex tasks. Friends and colleagues may begin to notice something is different, but the individual may still be able to work, drive, and socialise. This is the stage at which intervention is most effective.

Middle Stage (Moderate)

This is often the longest stage and requires increasing support. Memory gaps widen, the person may forget significant personal history or fail to recognise familiar faces. Communication becomes more difficult. Behavioural changes become more pronounced, including restlessness, sleep disturbances, and increased confusion, particularly in the evening. Personal care tasks like dressing and bathing may require assistance.

Late Stage (Severe)

The person loses the ability to communicate verbally and requires full-time care for all daily activities. Physical functions, including mobility, swallowing, and bladder and bowel control, are progressively lost. The risk of infection, particularly pneumonia, increases significantly. Comfort, dignity, and quality of life become the primary focus of care at this stage.

Treatment — What’s Available and What It Actually Does

It is important to be honest about what Alzheimer’s disease treatment can and cannot do. There is currently no cure for Alzheimer’s disease. Treatment aims to manage symptoms, maintain quality of life, and in some cases slow the pace of cognitive decline.

Cholinesterase inhibitors (such as donepezil, rivastigmine, and galantamine) are prescribed for mild to moderate Alzheimer’s. They work by preventing the breakdown of acetylcholine, a neurotransmitter involved in memory and learning, thereby temporarily supporting cognitive function.

Memantine is used in moderate to severe stages and helps regulate glutamate activity in the brain, which can reduce some symptoms of confusion and agitation.

Newer disease-modifying therapies targeting amyloid plaques directly have received regulatory approval in some countries and represent a significant shift in how Alzheimer’s may be treated in the future. Availability and suitability depend on the stage of disease and the treating physician’s assessment.

Non-pharmacological interventions structured cognitive stimulation, music therapy, physical activity, and caregiver education, play a meaningful role in maintaining quality of life and reducing behavioural symptoms, particularly in the middle stages.

For patients and families seeking comprehensive Alzheimer’s disease treatment in India, specialist neurological centres with dedicated memory clinics offer the most structured and evidence-based approach to management.

How Alzheimer’s Is Diagnosed in India

Alzheimer’s disease diagnosis in India follows a structured clinical process:

  • Detailed clinical history — the physician will take a comprehensive account of symptom onset, progression, and impact on daily function, often with input from a family member or caregiver
  • Cognitive and neuropsychological assessments — standardised tools such as the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) evaluate memory, language, attention, and executive function
  • Blood tests — to rule out reversible causes of cognitive decline, including thyroid dysfunction, vitamin B12 deficiency, and metabolic disorders
  • Brain imaging — MRI or CT scans assess brain structure, identify atrophy patterns consistent with Alzheimer’s, and exclude other conditions such as stroke or tumour
  • PET scan or CSF biomarker testing — in specialised centres, these can directly detect amyloid and tau deposits in the brain, supporting earlier and more precise diagnosis

Early and accurate diagnosis not only enables timely treatment but also allows patients and families to plan ahead, legally, financially, and practically, while the patient can still participate meaningfully in those decisions.

When to See a Doctor — And Who to Call

A neurologist or psychiatrist with expertise in cognitive disorders should be consulted when:

  • A family member’s memory lapses are becoming frequent, severe, or affecting daily function
  • There are noticeable changes in personality, behaviour, or communication that cannot be attributed to depression, stress, or physical illness
  • The person is becoming confused in familiar environments, struggling with previously manageable tasks, or repeating questions and stories
  • A family member has been diagnosed and other family members want to understand their own risk profile

The best psychiatrist hospital in Mumbai with a dedicated neurology and memory disorders unit offers the multidisciplinary expertise including neurologists, neuropsychologists, geriatricians, and social workers required by Alzheimer’s management. The same centre also provides specialised care for other neurodegenerative conditions, including Parkinson’s treatment in Mumbai, ensuring continuity of care for patients and families navigating complex neurological diagnoses. 

 Conclusion

Alzheimer’s disease is not an inevitable consequence of ageing, and treating it as such is one of the most consequential mistakes a family can make. The disease is progressive, the damage it causes is irreversible, and the window for meaningful intervention is widest at the earliest stages, which are precisely the stages most likely to be dismissed or overlooked.

Recognising the difference between normal ageing and genuine cognitive decline, understanding the risk factors, and knowing when to seek specialist evaluation are not just medical considerations. They are decisions that shape the quality and dignity of life for both the person with Alzheimer’s and the family that surrounds them.

If you have concerns about a loved one’s memory, behaviour, or cognitive function, do not wait for certainty before seeking evaluation. At Kokilaben Dhirubhai Ambani Hospital, our neurology and psychiatry teams provide expert assessment and personalised care for patients at every stage of cognitive decline. Early consultation changes outcomes. Book an appointment today.

Frequently Asked Questions

Is Alzheimer’s disease hereditary? 

Partially. Having a close biological relative with Alzheimer’s increases your risk. Specific gene variants, particularly APOE ε4, raise susceptibility further. However, genetics is one factor among many, most people with a family history do not develop the disease.

At what age does Alzheimer’s disease usually start in India? The majority of cases are diagnosed after the age of 65, with risk increasing significantly in the 70s and 80s. However, early-onset Alzheimer’s, occurring before 65 – does occur, though it is less common.

Can a young person get Alzheimer’s disease?  

Yes. Early-onset Alzheimer’s can affect people in their 40s and 50s. It accounts for a small proportion of all Alzheimer’s cases but is often more aggressive in its progression. Genetic mutations are more commonly implicated in early-onset forms.

What is the difference between Alzheimer’s and dementia? 

Dementia is an umbrella term for a group of symptoms involving decline in memory, reasoning, and daily function. Alzheimer’s disease is the most common cause of dementia, responsible for the majority of cases. Not all dementia is Alzheimer’s, other causes include vascular dementia, Lewy body dementia, and frontotemporal dementia.

Why Do Kidney Stones Hurt So Much? Doctors Say It’s One of the Worst Pains Known

Sunday, May 3rd, 2026

If you’ve ever seen someone go through a kidney stone attack, you already know something simple: words never fully capture how bad it is. People often say it feels like being stabbed from the inside, or describe waves of crushing pain that hit without warning and without relief. Doctors consistently rank kidney stone pain among the most intense a person can experience, and there’s a very specific anatomical reason for that. 

Dr. Shyam Varma

● Author

Dr. Shyam Varma

Urology  ·  Renal Transplant & Robotic Surgery

Consultant, Urologist & Renal Transplant Surgeon

MS, MCh Urology, Fellowship Laparoscopic Urology & Transplant  ·  KDAH Mumbai  ·  English, Hindi, Marathi, Telugu


18+
Years Exp.
400+
Transplants
1750+
Laser Surgeries
AUA
Member

What Is Actually Happening Inside Your Body?

When a stone gets stuck in the ureter, it blocks the normal flow of urine. The kidney keeps making urine, pressure builds behind the blockage, and the kidney begins to stretch and swell. This is called hydronephrosis. The stretching, along with strong muscle spasms in the ureter as it tries to push the stone forward, is what makes the pain feel unbearable.

These stones can be as small as a grain of sand or, in rare cases, large enough to fill the kidney cavity (a staghorn calculus). Size matters, but not always in the way you might expect. Even a stone just a few millimetres wide can cause severe pain as it moves through the ureter, the narrow tube that connects each kidney to the bladder.

When a stone becomes lodged in the ureter, it obstructs the normal flow of urine. The kidney continues to produce urine, pressure builds up behind the blockage, and the kidney starts to stretch and swell, a condition known as hydronephrosis. This stretching, combined with powerful muscular spasms of the ureter as it tries to push the stone along, is what leads many patients to describe the pain as unbearable.

Why does it hurt so much?

Kidney stone pain is so strong because several things happen at once. These usually do not happen together in other conditions.

  • Ureter spasms: The ureter is a narrow tube that carries urine from the kidney to the bladder. When a stone gets stuck, the ureter squeezes hard again and again to try to move it. This is why the pain often comes in waves.
  • Pressure and swelling: When urine cannot pass easily, pressure builds up and the kidney swells. The kidney does not stretch much, so this pressure causes deep, intense pain.
  • No comfortable position: Unlike many other pains, kidney stone pain usually does not improve when you lie down, sit up, or change position. It can be hard to find any position that feels better.
  • Pain can spread: Pain signals travel through nerves that make it hard for the brain to tell exactly where the pain is coming from. That is why the pain may spread to the groin, lower stomach, or inner thigh.

What causes kidney stones in the first place?

Knowing what causes kidney stones can help you understand why they form and how to lower the chance of getting them again. Common causes include:

Not drinking enough water: When you do not drink enough fluids, minerals in your urine become more concentrated and can form stones.

A diet high in salt or protein: Too much salt, red meat, and processed food can raise the amount of calcium and other stone forming substances in the urine.

Foods high in oxalate: Eating a lot of foods like spinach, nuts, chocolate, and strong tea can increase the chance of calcium oxalate stones in some people.

Family history: If a close family member has had kidney stones, your risk is higher too.

Certain health conditions: Gout, diabetes, hyperparathyroidism, and obesity can change how the body handles minerals and make stones more likely.

Repeated urinary tract infections: These can lead to a type of stone called struvite stones, which are often linked to infection.

Some medicines: Certain medicines, including calcium based antacids and some diuretics, may increase the risk in people who are already prone to stones.

By finding out which of these risk factors apply to you, your care team can make a treatment and prevention plan that is right for you.

Where Does Kidney Stone Pain Typically Occur?

Kidney stone symptoms can vary depending on the stone’s position in the urinary tract at any given time. Pain typically begins in the back, just below the ribcage, on either side of the spine (the flank area). As the stone moves down toward the bladder, the pain shifts forward into the lower abdomen, the groin, and sometimes the inner thigh.

Here is a general map of pain location by stone position:

  • Stone in the kidney: Dull, aching flank pain often dismissed initially as a muscle pull
  • Stone in the upper ureter: Severe flank pain radiating to the abdomen; nausea is common
  • Stone in the middle ureter: Pain migrates forward and downward toward the groin
  • Stone at the ureterovesical junction (where the ureter meets the bladder): Burning sensation during urination, frequent urge to urinate, pain in the pelvic region

How Does Kidney Stone Pain Compare to Other Extreme Pains?

Doctors and patients who have experienced both kidney stones and other acutely painful events frequently rank kidney stone pain alongside childbirth, broken bones, and acute pancreatitis as among the most severe pains the human body can produce. What makes it particularly brutal is its unpredictability; attacks often begin with no warning and escalate within minutes to maximum intensity.

Unlike some forms of severe pain that occur once and resolve, kidney stones can recur. Individuals who have had one stone have a significantly elevated risk of forming another within a decade without lifestyle changes or medical management.

Additional symptoms beyond pain

Kidney stones can cause more than flank pain. Other symptoms may include:

Blood in the urine: The urine may look pink, red, or brown.

Nausea and vomiting: This can happen because the pain is so severe.

Burning or pain while urinating: This is more common when the stone moves lower down.

A frequent urge to urinate: You may feel like you need to go often, even if little comes out.

Cloudy or bad smelling urine: This may be a sign of a urinary tract infection.

Fever and chills: These are warning signs. A fever with kidney stone pain may mean there is a kidney infection and needs urgent medical care.

If you have a fever with kidney stone symptoms, do not try to manage it at home. Visit the hospital right away.

Why do some people experience no pain at all?

Not all kidney stones cause pain. Stones that stay in the kidney without blocking urine flow, sometimes called silent stones, may cause no symptoms for months or even years. They are often found by chance during an imaging test done for another reason.

The main factor is movement and blockage. A stone that stays in the kidney is different from one that moves into the ureter. Even silent stones should be monitored because they can shift and cause a sudden blockage without warning.

Why are Indians particularly prone to kidney stones?

India has one of the highest rates of kidney stones in the world. Climate, diet, and daily habits all play a role.

Hot weather and sweating: In many parts of India, people lose a lot of fluid through sweat. If they do not replace it by drinking enough water, urine becomes concentrated, which increases the risk of stone formation.

Diet: A diet high in salt, spinach, and protein can raise the level of stone forming minerals in the urine.

Not drinking enough water: Many people, especially those who work outdoors or do physical labour, do not drink enough water during the day.

Family history: Some people have a higher risk because kidney stones run in the family.

Delayed treatment: Early kidney stone pain can feel like back pain or stomach trouble, so many people do not seek care right away.

For Mumbai residents, heat, humidity, and a high salt diet can make the risk even higher. Staying well hydrated and going for regular health check ups can help lower the chance of kidney stones.

What to do during a kidney stone attack

If you are having a kidney stone attack:

Drink water slowly and steadily. Do not drink a large amount at once, as small, regular sips may help.

Take pain relief such as paracetamol or ibuprofen, if it is safe for you, while you get medical care. 

Keep track of your symptoms. Note when the pain started, where it is felt, whether there is blood in your urine, and whether you have a fever.

Strain your urine, if possible, to catch any stone that passes. This can help your doctor identify the type of stone.

Go to a hospital right away if you have a fever, cannot urinate, or the pain becomes too strong to manage. These may be signs of a serious problem that needs urgent treatment.

Treatment: From Waiting It Out to Surgery

The right treatment for a kidney stone depends on its size and location, how severe the symptoms are, and whether there is infection or blockage.

Conservative management, or wait and pass

Smaller stones, usually under 5 mm, often pass on their own with enough fluids and pain relief. Doctors may also prescribe medicines that relax the ureter and help the stone pass more easily.

Shock wave lithotripsy (ESWL)

This noninvasive treatment uses sound waves to break the stone into smaller pieces so they can pass naturally. It is usually used for stones in the kidney or upper ureter.

Ureteroscopy (URS)

A thin, flexible scope is passed through the urethra and bladder into the ureter to find the stone directly. The stone can then be removed or broken into smaller pieces with a laser. This treatment works well for stones in the middle or lower ureter.

Retrograde Intrarenal Surgery (RIRS)

RIRS is a minimally invasive procedure used to treat kidney stones or stones in the upper ureter when ESWL or standard ureteroscopy is not suitable. A flexible ureteroscope is passed through the natural urinary passage and moved into the kidney without any incision. Once the stone is seen, a laser is used to break it into very small pieces that are either removed or passed naturally. RIRS is particularly suitable for:

  • Stones between 1 and 2 cm in size
  • Stones in hard to reach areas of the kidney
  • Patients for whom ESWL has not worked
  • Patients for whom PCNL carries a higher surgical risk

Because there is no external incision, recovery is usually faster, and the risk of bleeding is lower than with PCNL.

Percutaneous Nephrolithotomy (PCNL)

For large stones, particularly those larger than 2 cm, PCNL involves making a small incision in the back to access the kidney directly and remove the stone. It is the preferred approach for staghorn calculi and complex cases.

Medical Therapy

Certain stones, particularly uric acid stones, can sometimes be dissolved with alkalising agents and dietary modification. Your nephrologist will advise based on stone composition analysis.

If you are looking for the best kidney stone hospital in Mumbai for diagnosis and surgical management, KDAH’s urology department offers a complete care pathway from investigation to treatment. 

Prevention: What Actually Works

Once you have had one kidney stone, the likelihood of developing another is high without deliberate preventive measures. Proven strategies include:

  • Drink 2.5 to 3 litres of water daily: enough to keep urine pale yellow; darker urine means concentration is too high
  • Reduce sodium intake: high sodium causes the kidneys to excrete more calcium into urine, which promotes calcium stone formation
  • Moderate animal protein consumption: excessive red meat and poultry increase uric acid production
  • Maintain a healthy weight: obesity is a known risk factor for both calcium and uric acid stones
  • Moderate oxalate intake: if you are prone to calcium oxalate stones, limit spinach, beets, nuts, and chocolate
  • Get a 24-hour urine analysis after your first stone: this test identifies specific metabolic risk factors and allows your doctor to tailor prevention precisely to your chemistry
  • Do not eliminate dairy: contrary to common belief, moderate calcium from food (not supplements) actually helps bind oxalate in the gut and prevents it from reaching the kidneys

How Are Kidney Stones Diagnosed at Kokilaben Dhirubhai Ambani Hospital?

At Kokilaben Dhirubhai Ambani Hospital, the approach to diagnosing kidney stones goes beyond confirming the presence of a stone. The goal is to understand the type, size, location, and metabolic backdrop that led to its formation.

 Diagnostic Investigations Available at Kokilaben Dhirubhai Ambani Hospital

  • CT KUB (Computed Tomography of Kidney, Ureter, and Bladder): the gold standard for kidney stone detection, providing precise size, location, and density measurements
  • Ultrasound of the abdomen and pelvis: first-line imaging for suspected stones; widely available, radiation-free, and useful for assessing kidney swelling
  • X-ray KUB: useful for calcium-containing stones, though not all stone types are visible
  • Urine analysis and culture: checks for blood, infection, and crystal types in urine
  • Blood tests: assess kidney function (creatinine, eGFR), calcium levels, and uric acid
  • 24-hour urine collection: for patients with recurrent stones, this detailed test analyses the daily output of stone forming and stone inhibiting substances

Kokilaben Dhirubhai Ambani’s urology team works closely with nephrology and dietetics to provide a unified management plan, from acute pain management to long term stone prevention. Patients requiring additional kidney care, including monitoring of kidney function after recurrent stone episodes, have access to an onsite dialysis centre in Mumbai if needed for advanced kidney disease management.

Conclusion

Kidney stone pain is not an exaggeration. It can be one of the most intense pains a person feels, and knowing why it happens can make it a little less frightening. The pain comes from the stone blocking the flow of urine and causing pressure and muscle spasms.

The good news is that kidney stones can often be treated well when they are found early. Whether you are in pain, have had stones before, or are worried about your risk, the most important step is to get checked by a doctor.

At Kokilaben Dhirubhai Ambani Hospital, our urology and nephrology teams provide complete kidney stone care, from pain relief and scans to stone removal and follow-up care to help prevent stones from coming back. If you are dealing with a stone right now, speak with a trusted urologist at KDAH to find the right treatment for you.

Frequently Asked Questions

Is kidney stone pain worse than childbirth? 

Many who have experienced both describe kidney stone pain as comparable to or worse than labour contractions. It escalates to peak intensity within minutes and offers no position of relief. That said, pain is subjective and varies from person to person.

How long does kidney stone pain last? 

Smaller stones may pass within a few hours to a few days. Larger ones can take several weeks. If pain persists beyond a few days or comes with fever or blood in the urine then you must seek a doctor immediately.

Can drinking lemon water help with kidney stones? 

Yes, as a preventive measure. Lemon juice contains citrate, which helps inhibit calcium oxalate stone formation. It is not, however, a treatment for a stone that is already blocking the urinary tract or causing an infection.

Should I avoid milk and dairy if I have kidney stones? 

No, this is a common misconception. Dietary calcium from milk, yoghurt, and cheese binds oxalate in the gut, reducing the amount that reaches the kidneys. Cutting dairy can paradoxically raise your risk. Calcium supplements are a different matter, discuss those with your doctor.

What size kidney stone requires surgery in India? 

Stones under 5 mm often pass on their own. Stones between 5–10 mm may need ureteroscopy. Anything above 10 mm, or stones causing obstruction or infection, typically requires surgical intervention. Your urologist will advise based on your specific case.